Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.Abstract:
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.read more
Citations
More filters
Journal ArticleDOI
LncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion.
Jian-kang Huang,Ling Ma,Wen-hua Song,Bang‐yu Lu,Yu-bin Huang,Hui-ming Dong,Xiao-kai Ma,Zheng-zhi Zhu,Rui Zhou +8 more
TL;DR: The results suggest that MALAT1‐mediated FGF2 protein secretion from TAMs inhibits inflammatory cytokines release, promotes proliferation, migration, and invasion of FTC133 cells and induces vasculature formation.
Journal ArticleDOI
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
Jie Wu,Zerun Jiang,Chen Chen,Qingsong Hu,Ziyi Fu,Junjie Chen,Zhangding Wang,Qiang Wang,Aiping Li,Jeffrey R. Marks,Changying Guo,Yun Chen,Jianwei Zhou,Liuqing Yang,Chunru Lin,Shouyu Wang +15 more
TL;DR: It is determined that the expression of a novel circRNA, which is named circIRAK3, was increased in metastatic breast cancer cells and predictive of BC recurrence and may be a potential target for metastatic BC therapy.
Journal ArticleDOI
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll,Morten Lapin,Tove Buhl,Satu Oltedal,Katrine Steen-Ottosen Berry,Bjørnar Gilje,Jon Arne Søreide,Jon Arne Søreide,Millind Javle,Oddmund Nordgård,Rune Smaaland +10 more
TL;DR: KRAS mutations were used to investigate the clinical relevance of circulating tumor DNA (ctDNA) measurements in patients with advanced pancreatic cancer and results were compared to conventional monitoring measures and survival data.
Journal ArticleDOI
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer
TL;DR: It is demonstrated that the expression of hepatocyte nuclear factor 1 homeobox A antisense RNA 1 (HNF1A-AS1) is significantly upregulated in gastric cancer tissues, implicating it as a possible target for therapeutic intervention in this disease.
Journal ArticleDOI
Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer.
Srinivasa R. Rao,Ann Snaith,D Marino,X Cheng,Seint T. Lwin,Isabel R. Orriss,Freddie C. Hamdy,Claire M. Edwards +7 more
TL;DR: The function of tumour-derived ALPL, the gene that encodes for tissue nonspecific ALP, is revealed in regulating cell death and epithelial plasticity, and a strong association between ALPL expression in PCa cells and metastasis or disease-free survival is demonstrated, identified as a major contributor to the pathogenesis of PCa progression.
References
More filters
Journal ArticleDOI
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.